Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
UBS analyst Danielle Antalffy maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $106 to $95.
Truist Securities analyst Richard Newitter reiterates DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $94 t...
Barclays analyst Matt Miksic maintains DexCom (NASDAQ:DXCM) with a Equal-Weight and lowers the price target from $98 to $80.
These ten large-cap stocks led last week's declines, including Fiserv, Alexandria Real Estate, Chipotle, eBay, after weak r...
Wells Fargo analyst Larry Biegelsen maintains DexCom (NASDAQ:DXCM) with a Overweight and lowers the price target from $98 to...
Canaccord Genuity analyst William Plovanic maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $106 t...
Citigroup analyst Joanne Wuensch maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $85 to $75.
JP Morgan analyst Robbie Marcus maintains DexCom (NASDAQ:DXCM) with a Neutral and lowers the price target from $90 to $75.
TD Cowen analyst Joshua Jennings maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $100 to $84.
